MetLife’s Trading Volume Surges 32.84% to Rank 445th as DOJ Challenges $2.2B Athene Deal Uncertainty Looms Over Strategic Growth

On September 15, 2025, , . Despite the elevated liquidity, .

Recent developments highlight regulatory scrutiny as the U.S. , citing antitrust concerns in the life insurance sector. The legal action has heightened uncertainty around the deal’s completion, with analysts noting potential implications for MetLife’s strategic growth plans and capital allocation strategies.

Separately, , signaling confidence in its balance sheet strength. The move aligns with MetLife’s broader capital management framework, .

Back-test parameters for evaluating trading strategies require precise definitions: the universe of U.S. stocks must clarify inclusion criteria (e.g., Russell 3000 eligibility), price execution timing (open vs. close), and cost assumptions (zero or 4 bps round-trip). These details will determine the accuracy of performance simulations for the top 500 stocks over the specified period.